OTOFERLIN GENE-MEDIATED HEARING LOSS

Clinical trials for OTOFERLIN GENE-MEDIATED HEARING LOSS explained in plain language.

Never miss a new study

Get alerted when new OTOFERLIN GENE-MEDIATED HEARING LOSS trials appear

Sign up with your email to follow new studies for OTOFERLIN GENE-MEDIATED HEARING LOSS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gene therapy for deafness: 5-Year safety watch begins

Disease control ENROLLING_BY_INVITATION

This study follows 30 people for up to five years after they received an experimental gene therapy for hearing loss. The goal is to monitor for any long-term safety issues and see if the treatment's benefits last. Participants had a specific type of genetic hearing loss and recei…

Matched conditions: OTOFERLIN GENE-MEDIATED HEARING LOSS

Sponsor: Akouos, Inc. • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

OTOFERLIN GENE-MEDIATED HEARING LOSS

Get alerted when new OTOFERLIN GENE-MEDIATED HEARING LOSS trials appear

Gene therapy for deafness: 5-Year safety watch begins